Stammdaten
Krystal Biotech, Inc., ein Biotechnologieunternehmen in der klinischen Phase, ist im Bereich der wiederholbaren Gentherapie zur Behandlung von schweren seltenen Krankheiten in den Vereinigten Staaten tätig. Sein führender Produktkandidat ist beremagene geperpavec (B-VEC), das sich in Phase III der klinischen Studie zur Behandlung von dystrophischer Epidermolysis bullosa befindet. Das Unternehmen ist auch an der Entwicklung von KB105 beteiligt, das sich in Phase I/II der klinischen Studie zur Behandlung von Patienten mit defizitärer autosomal-rezessiver kongenitaler Ichthyose befindet; KB301, das sich in Phase I/II des klinischen Stadiums zur Behandlung von Falten und anderen Erscheinungsformen von gealterter oder beschädigter Haut befindet; KB407, das sich in präklinischem Stadium für Mukoviszidose befindet; und KB104, das sich in präklinischem Stadium für Netherton-Syndrom befindet. Seine Produktkandidaten im Entdeckungsstadium umfassen KB5xx zur Behandlung chronischer Hauterkrankungen, KB3xx zur Behandlung ästhetischer Hautzustände und ein KB3xx-Produkt. Krystal Biotech, Inc. wurde 2015 gegründet und hat seinen Hauptsitz in Pittsburgh, Pennsylvania. KI
Unternehmen & Branche
| Name | Krystal Biotech, Inc. |
|---|---|
| Ticker | KRYS |
| CIK | 0001711279 |
| Börse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 501147102 |
|---|---|
| ISIN | US5011471027 |
| Typ | Common Stock |
| Marktkapitalisierung | 9,90 Mrd. USD |
| KGV (P/E) | 49,59 |
| Beta | 0,49 |
Sitz & Kontakt
| Geschäftsadresse | 2100 WHARTON STREET SUITE 701, 15203 PITTSBURGH, PA |
|---|---|
| Telefon | (412) 586-5830 |
| EIN (IRS) | 82-1080209 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KBV (P/B) | 8,12 vs. 2,97 (2021) ▲ |
|---|---|
| KUV (P/S) | 25,45 |
| EV/EBITDA | 56,4 |
| FCF-Rendite | 1,9 % vs. -6,6 % (2021) ▲ |
Qualität & Bilanz
| Operative Marge | 41,5 % |
|---|---|
| Nettomarge | 52,6 % |
| ROIC | 16,7 % vs. -11,6 % (2021) ▲ |
| Nettoverschuldung/EBITDA | -2,9 |
| Forderungslaufzeit (DSO) | 120 T |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 2,97 | 3,91 | 4,50 | 4,77 | 5,90 | 7,76 | |
| KUV (P/S) | – | – | 69,10 | 15,53 | 18,50 | 23,73 | |
| EV/EBITDA | – | – | – | 58,2 | 40,2 | 51,0 | |
| FCF-Rendite | -6,6 % | -7,5 % | -2,9 % | 2,6 % | 2,6 % | 2,4 % | |
| Qualität & Bilanz | |||||||
| Operative Marge | – | – | -216,2 % | 22,6 % | 41,5 % | 42,8 % | |
| Nettomarge | – | – | 21,6 % | 30,7 % | 52,6 % | 53,9 % | |
| ROIC | -11,6 % | -26,4 % | 1,4 % | 9,3 % | 16,7 % | 17,5 % | |
| Nettoverschuldung/EBITDA | – | – | – | -4,7 | -2,9 | -2,7 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
KRYS
Krystal Biotech, Inc.
Effektiv
Neutral
Handelsvolumen
Hoch
Insider
0,0
Keine Insider-Käufe
Institutionell
38,6
73 neu, 139 erhöht, -146380K $ netto
Aktivist
10,5
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 330.61 | +2.6 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 265.38 | +27.8 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 350.45 | EMA50: 332.21 | |
| MACD-Histogramm | Bärisch | 10 % | -5.550 | Bearisch | |
| RSI(14) | Neutral | 10 % | 46.1 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 24.6 | Neutral | |
| ADX(14)+DI | Bärisch | 10 % | 28.5 | +DI: 16.5 / −DI: 21.2 | |
| Z-Score(60) | Neutral | 5 % | 0.53 | In Range | |
| 52W-Position | Bullisch | 5 % | 83.9 % | Hoch 378.15 / Tief 134.94 | |
| Bollinger(20,2σ) | Bullisch | 5 % | 12.8 % | Upper 388.18 / Mid 360.01 / Lower 331.85 | |
| LinReg-Slope(60) | Bullisch | 10 % | +1.6717 | R²=0.78 / annualisiert +131.0 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-25 | Thomas John Charles | Officer, EVP, General Counsel | Open Market Sale | -1.000 | 347,27 | -347.270,00 | -47,4% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -247 | 303,17 | -74.883,06 | -10,2% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -240 | 311,65 | -74.796,00 | -10,2% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -11.461 | 307,68 | -3.526.292,97 | -481,6% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -4.830 | 308,47 | -1.489.898,99 | -203,5% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.784 | 309,49 | -861.620,44 | -117,7% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.652 | 310,43 | -823.257,71 | -112,4% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -320 | 300,75 | -96.240,00 | -13,1% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -964 | 311,36 | -300.149,11 | -41,0% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -640 | 302,24 | -193.431,49 | -26,4% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -589 | 306,33 | -180.429,43 | -24,6% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -544 | 304,81 | -165.816,75 | -22,6% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -320 | 300,75 | -96.240,00 | -13,1% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -176 | 303,17 | -53.357,73 | -7,3% | |
| 2026-06-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -40 | 312,23 | -12.489,20 | -1,7% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -12.729 | 307,81 | -3.918.070,21 | -535,1% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -3.803 | 308,89 | -1.174.707,91 | -160,4% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.801 | 309,95 | -868.156,23 | -118,6% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.039 | 310,94 | -634.000,54 | -86,6% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -1.348 | 307,09 | -413.963,79 | -56,5% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -593 | 302,25 | -179.234,72 | -24,5% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -480 | 305,87 | -146.815,20 | -20,1% | |
| 2026-06-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -400 | 304,89 | -121.957,56 | -16,7% | |
| 2026-05-26 | Thomas John Charles | Officer, EVP, General Counsel | Open Market Sale | -642 | 302,03 | -193.903,26 | -26,5% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -8.798 | 264,85 | -2.330.151,18 | -318,2% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -3.128 | 260,49 | -814.802,40 | -111,3% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.962 | 261,41 | -774.289,02 | -105,7% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.439 | 265,59 | -647.773,03 | -88,5% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.380 | 262,44 | -624.618,62 | -85,3% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.043 | 263,70 | -538.741,35 | -73,6% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -1.377 | 259,87 | -357.837,55 | -48,9% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -920 | 266,56 | -245.230,60 | -33,5% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -483 | 257,31 | -124.282,23 | -17,0% | |
| 2026-03-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -470 | 258,38 | -121.438,37 | -16,6% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -1.700 | 266,42 | -452.918,08 | -61,9% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -6.000 | 265,16 | -1.590.979,20 | -217,3% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -4.852 | 264,64 | -1.284.019,21 | -175,4% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -3.667 | 260,37 | -954.762,49 | -130,4% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.931 | 261,41 | -766.198,28 | -104,6% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.248 | 263,58 | -592.534,81 | -80,9% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -1.938 | 262,35 | -508.430,23 | -69,4% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -407 | 257,32 | -104.728,67 | -14,3% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -589 | 258,54 | -152.280,30 | -20,8% | |
| 2026-03-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -668 | 259,61 | -173.419,15 | -23,7% | |
| 2026-03-02 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -750 | 267,60 | -200.700,00 | -27,4% | |
| 2026-02-27 | JANNEY DANIEL | Director | Open Market Sale | -2.373 | 276,17 | -655.343,10 | -89,5% | |
| 2026-02-27 | JANNEY DANIEL | Director | Open Market Sale | -9.430 | 275,45 | -2.597.481,24 | -354,7% | |
| 2026-02-26 | JANNEY DANIEL | Director | Open Market Sale | -2.638 | 276,32 | -728.919,50 | -99,5% | |
| 2026-02-26 | JANNEY DANIEL | Director | Open Market Sale | -5.103 | 275,28 | -1.404.759,96 | -191,9% | |
| 2026-02-25 | JANNEY DANIEL | Director | Open Market Sale | -700 | 275,00 | -192.500,00 | -26,3% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -4.339 | 266,62 | -1.156.878,93 | -158,0% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -62 | 263,05 | -16.309,17 | -2,2% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -370 | 269,83 | -99.836,43 | -13,6% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -373 | 271,09 | -101.117,99 | -13,8% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -569 | 262,91 | -149.594,08 | -20,4% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -900 | 264,60 | -238.136,04 | -32,5% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -930 | 269,50 | -250.636,21 | -34,2% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -1.604 | 265,54 | -425.919,10 | -58,2% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -1.674 | 268,67 | -449.746,88 | -61,4% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -1.733 | 264,12 | -457.727,93 | -62,5% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -1.891 | 267,37 | -505.596,67 | -69,1% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -2.425 | 274,90 | -666.626,92 | -91,0% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -3.557 | 265,08 | -942.878,18 | -128,8% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -3.963 | 268,97 | -1.065.923,75 | -145,6% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -6.671 | 268,04 | -1.788.079,50 | -244,2% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -8.986 | 266,18 | -2.391.885,39 | -326,7% | |
| 2026-02-24 | JANNEY DANIEL | Director | Open Market Sale | -11.673 | 266,97 | -3.116.310,46 | -425,6% | |
| 2026-02-19 | ROSSI DINO A | Director | Open Market Sale | -10.834 | 262,10 | -2.839.591,40 | -387,8% | |
| 2026-02-19 | ROSSI DINO A | Director | Open Market Sale | -8.116 | 260,49 | -2.114.102,75 | -288,7% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -552 | 274,64 | -151.600,62 | -20,7% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -400 | 275,68 | -110.272,00 | -15,1% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -96 | 277,88 | -26.676,48 | -3,6% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -5.700 | 271,66 | -1.548.477,39 | -211,5% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -2.000 | 270,56 | -541.115,80 | -73,9% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -2.824 | 272,51 | -769.562,31 | -105,1% | |
| 2026-02-09 | ROMANO KATHRYN | Officer, Chief Accounting Officer | Open Market Sale | -928 | 273,71 | -254.000,56 | -34,7% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -1.600 | 217,04 | -347.271,68 | -47,4% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -1.400 | 216,97 | -303.753,52 | -41,5% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -956 | 214,28 | -204.851,39 | -28,0% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -700 | 222,20 | -155.539,02 | -21,2% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -700 | 214,25 | -149.975,21 | -20,5% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -600 | 215,49 | -129.295,98 | -17,7% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -344 | 215,48 | -74.125,60 | -10,1% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -200 | 222,38 | -44.475,00 | -6,1% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -10.505 | 221,78 | -2.329.771,59 | -318,2% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -10.461 | 221,82 | -2.320.470,53 | -316,9% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -5.693 | 219,53 | -1.249.803,08 | -170,7% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -5.419 | 219,68 | -1.190.422,62 | -162,6% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -3.593 | 218,83 | -786.244,69 | -107,4% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.627 | 220,52 | -579.300,52 | -79,1% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.625 | 220,34 | -578.394,60 | -79,0% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -2.577 | 218,72 | -563.637,83 | -77,0% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -1.600 | 217,04 | -347.271,68 | -47,4% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -1.400 | 216,97 | -303.753,52 | -41,5% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -956 | 214,28 | -204.851,39 | -28,0% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -700 | 222,20 | -155.539,02 | -21,2% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -700 | 214,25 | -149.975,21 | -20,5% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -600 | 215,49 | -129.295,98 | -17,7% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -200 | 222,38 | -44.475,00 | -6,1% | |
| 2025-12-04 | Krishnan Suma | Director, Officer, 10% Owner, President, R&D | Open Market Sale | -344 | 215,48 | -74.125,60 | -10,1% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -10.505 | 221,78 | -2.329.771,59 | -318,2% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -10.461 | 221,82 | -2.320.470,53 | -316,9% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -5.693 | 219,55 | -1.249.916,94 | -170,7% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -5.419 | 219,68 | -1.190.422,62 | -162,6% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -3.593 | 218,83 | -786.244,69 | -107,4% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.627 | 220,52 | -579.300,52 | -79,1% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.625 | 220,34 | -578.394,60 | -79,0% | |
| 2025-12-04 | Krishnan Krish S | Director, Officer, 10% Owner, President and CEO | Open Market Sale | -2.577 | 218,72 | -563.637,83 | -77,0% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 1932 von typischerweise 8378 Fonds (23 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| FMR LLC | 4.373.987 | 0 | 4.373.987 | 1.129.888.252 | Neu | +100,0% | |
| BlackRock, Inc. | 3.940.456 | 0 | 3.940.456 | 1.017.898.595 | Neu | +100,0% | |
| Avoro Capital Advisors LLC | 2.888.888 | 0 | 2.888.888 | 746.257.548 | Neu | +100,0% | |
| STATE STREET CORP | 1.314.434 | 0 | 1.314.434 | 339.544.591 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.165.324 | 0 | 1.165.324 | 301.026.496 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 1.153.087 | 0 | 1.153.087 | 297.865.434 | Neu | +100,0% | |
| Capital World Investors | 824.720 | 0 | 824.720 | 213.041.670 | Neu | +100,0% | |
| Redmile Group, LLC | 673.505 | 0 | 673.505 | 173.979.812 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 643.975 | 0 | 643.975 | 166.383.833 | Neu | +100,0% | |
| Hood River Capital Management LLC | 619.586 | 0 | 619.586 | 160.051.456 | Neu | +100,0% | |
| Bellevue Group AG | 481.785 | 0 | 481.785 | 124.454.701 | Neu | +100,0% | |
| Frazier Life Sciences Management, L.P. | 481.307 | 0 | 481.307 | 124.331.224 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 468.990 | 0 | 468.990 | 121.130.310 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 407.178 | 0 | 407.178 | 105.182.221 | Neu | +100,0% | |
| FIRST TRUST ADVISORS LP | 350.521 | 0 | 350.521 | 90.546.584 | Neu | +100,0% | |
| Janus Henderson Group Ltd. | 266.659 | 0 | 266.659 | 68.878.997 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 260.647 | 0 | 260.647 | 67.330.333 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 252.463 | 0 | 252.463 | 65.216.242 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 241.986 | 0 | 241.986 | 62.509.824 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 214.949 | 0 | 214.949 | 55.525.626 | Neu | +100,0% | |
| MORGAN STANLEY | 209.082 | 0 | 209.082 | 54.010.448 | Neu | +100,0% | |
| Caption Management, LLC | 190.000 | 0 | 190.000 | 49.080.800 | Neu | +100,0% | |
| BRAIDWELL LP | 182.425 | 0 | 182.425 | 47.124.026 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 179.265 | 0 | 179.265 | 46.307.673 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 164.842 | 0 | 164.842 | 42.581.985 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 162.070 | 0 | 162.070 | 41.865.924 | Neu | +100,0% | |
| UBS Group AG | 159.625 | 0 | 159.625 | 41.234.331 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 156.064 | 0 | 156.064 | 39.534.516 | Neu | +100,0% | |
| Woodline Partners LP | 150.616 | 0 | 150.616 | 38.907.125 | Neu | +100,0% | |
| Nuveen, LLC | 143.368 | 0 | 143.368 | 37.034.822 | Neu | +100,0% | |
| TimesSquare Capital Management, LLC | 112.342 | 0 | 112.342 | 29.020.185 | Neu | +100,0% | |
| Pictet Asset Management Holding SA | 110.665 | 0 | 110.665 | 28.586.983 | Neu | +100,0% | |
| VOYA INVESTMENT MANAGEMENT LLC | 108.397 | 0 | 108.397 | 28.001.113 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 93.031 | 0 | 93.031 | 24.031.768 | Neu | +100,0% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 92.286 | 0 | 92.286 | 23.839.320 | Neu | +100,0% | |
| S SQUARED TECHNOLOGY, LLC | 86.215 | 0 | 86.215 | 22.271.059 | Neu | +100,0% | |
| SEGALL BRYANT & HAMILL, LLC | 79.497 | 0 | 79.497 | 20.535.665 | Neu | +100,0% | |
| Biondo Investment Advisors, LLC | 72.045 | 0 | 72.045 | 18.610.664 | Neu | +100,0% | |
| ORBIMED ADVISORS LLC | 69.100 | 0 | 69.100 | 17.849.912 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 68.343 | 0 | 68.343 | 17.654.364 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 68.099 | 0 | 68.099 | 17.591.306 | Neu | +100,0% | |
| ACT CAPITAL MANAGEMENT, LLC | 60.477 | 0 | 60.477 | 15.622.419 | Neu | +100,0% | |
| Legal & General Group Plc | 59.050 | 0 | 59.050 | 15.253.796 | Neu | +100,0% | |
| CONGRESS ASSET MANAGEMENT CO | 40.134 | 0 | 40.134 | 14.916.604 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 49.837 | 0 | 49.837 | 12.873.894 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 46.570 | 0 | 46.570 | 12.029.924 | Neu | +100,0% | |
| Bridgewater Associates, LP | 46.367 | 0 | 46.367 | 11.977.523 | Neu | +100,0% | |
| SEB Asset Management AB | 46.343 | 0 | 46.343 | 11.971.309 | Neu | +100,0% | |
| Palisades Investment Partners, LLC | 45.405 | 0 | 45.405 | 11.729.474 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 43.318 | 0 | 43.318 | 11.189.906 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 1932 von typischerweise 8378 Fonds (23 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| CONGRESS ASSET MANAGEMENT CO | 40.134 | 0 | +100,0% | 14.916.604 | 40,96 | 100 % | 1 Q |
| Louisiana State Employees Retirement System | 11.500 | 11.400 | +0,9% | 4.274.205 | 11,74 | 100 % | 9 Q |
| YOUSIF CAPITAL MANAGEMENT, LLC | 7.192 | 7.131 | +0,9% | 2.673.051 | 7,34 | 26 % | 9 Q |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 6.222 | 6.382 | -2,5% | 2.312.531 | 6,35 | 100 % | 9 Q |
| TOTH FINANCIAL ADVISORY CORP | 4.511 | 6 | +75083,3% | 1.676.604 | 4,60 | 12 % | 2 Q |
| Confluence Wealth Services, Inc. | 3.792 | 2.922 | +29,8% | 1.409.373 | 3,87 | 0 % | 13 Q |
| Ellsworth Advisors, LLC | 3.268 | 3.245 | +0,7% | 1.144.584 | 3,14 | 0 % | 2 Q |
| Cornell Pochily Investment Advisors, Inc. | 2.515 | 0 | +100,0% | 934.750 | 2,57 | 0 % | 1 Q |
| Crossmark Global Holdings, Inc. | 2.186 | 2.294 | -4,7% | 812.471 | 2,23 | 100 % | 9 Q |
| Ballentine Partners, LLC | 2.138 | 2.115 | +1,1% | 794.630 | 2,18 | 0 % | 13 Q |
| QRG CAPITAL MANAGEMENT, INC. | 1.501 | 1.281 | +17,2% | 557.877 | 1,53 | 100 % | 2 Q |
| Mirae Asset Global Investments Co., Ltd. | 1.318 | 1.525 | -13,6% | 489.861 | 1,35 | 100 % | 15 Q |
| Hidden Cove Wealth Management, LLC | 1.220 | 1.302 | -6,3% | 453.437 | 1,25 | 100 % | 3 Q |
| Net Worth Advisory Group | 1.207 | 1.307 | -7,7% | 448.776 | 1,23 | 100 % | 3 Q |
| Fifth Third Wealth Advisors LLC | 1.109 | 1.019 | +8,8% | 412.182 | 1,13 | 100 % | 2 Q |
| Linden Thomas Advisory Services, LLC | 1.064 | 1.072 | -0,7% | 395.457 | 1,09 | 0 % | 2 Q |
| GAMMA Investing LLC | 998 | 858 | +16,3% | 370.927 | 1,02 | 100 % | 11 Q |
| Sequoia Financial Advisors, LLC | 923 | 993 | -7,0% | 343.052 | 0,94 | 0 % | 3 Q |
| Hennion & Walsh Asset Management, Inc. | 906 | 0 | +100,0% | 336.733 | 0,92 | 100 % | 14 Q |
| EXCHANGE TRADED CONCEPTS, LLC | 714 | 688 | +3,8% | 265.372 | 0,73 | 52 % | 4 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 51 | 0,2 | 39 |
| 31.03.2026 | ✓ | 364 | 30,0 | 7.525 |
| 31.12.2025 | ✓ | 329 | 31,7 | 7.599 |
| 30.09.2025 | ✓ | 281 | 28,5 | 4.891 |
| 30.06.2025 | ✓ | 270 | 27,7 | 3.704 |
| 31.03.2025 | ✓ | 293 | 28,6 | 4.921 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.165.324 | 301.026.496 |
| SEB Asset Management AB | 46.343 | 11.971.309 |
| GILDER GAGNON HOWE & CO LLC | 40.128 | 10.365.865 |
| Lisanti Capital Growth, LLC | 18.515 | 4.782.795 |
| ZACKS INVESTMENT MANAGEMENT | 17.919 | 4.628.710 |
| Campbell & CO Investment Adviser LLC | 17.795 | 4.596.804 |
| CIM, LLC | 14.990 | 3.872.217 |
| Atika Capital Management LLC | 10.625 | 2.744.650 |
| BROWN CAPITAL MANAGEMENT LLC | 9.247 | 2.388.685 |
| Aquatic Capital Management LLC | 8.257 | 2.132.948 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| Soleus Capital Management, L.P. | 1.153.087 | 212.028 | +22.5 % | 297.865.434 |
| FIRST TRUST ADVISORS LP | 350.521 | 105.245 | +42.9 % | 90.546.584 |
| RAYMOND JAMES FINANCIAL INC | 156.064 | 79.526 | +103.9 % | 39.534.516 |
| Bellevue Group AG | 481.785 | 71.462 | +17.4 % | 124.454.701 |
| BANK OF AMERICA CORP /DE/ | 260.647 | 69.840 | +36.6 % | 67.330.333 |
| FRANKLIN RESOURCES INC | 179.265 | 53.590 | +42.6 % | 46.307.673 |
| Janus Henderson Group Ltd. | 266.659 | 47.219 | +21.5 % | 68.878.997 |
| BNP PARIBAS FINANCIAL MARKETS | 93.031 | 39.120 | +72.6 % | 24.031.768 |
| Bridgewater Associates, LP | 46.367 | 36.352 | +363.0 % | 11.977.523 |
| GEODE CAPITAL MANAGEMENT, LLC | 643.975 | 32.097 | +5.2 % | 166.383.833 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 2.726 | -383.779 | -99.3 % | 704.180 |
| MARSHALL WACE, LLP | 68.343 | -115.411 | -62.8 % | 17.654.364 |
| GOLDMAN SACHS GROUP INC | 214.949 | -78.576 | -26.8 % | 55.525.626 |
| BARCLAYS PLC | 4.969 | -55.093 | -91.7 % | 1.283.592 |
| ORBIMED ADVISORS LLC | 69.100 | -50.700 | -42.3 % | 17.849.912 |
| Pictet Asset Management Holding SA | 110.665 | -45.903 | -29.3 % | 28.586.983 |
| Nuveen, LLC | 143.368 | -45.726 | -24.2 % | 37.034.822 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 485.074 | -44.881 | -8.5 % | 125.305 |
| JPMORGAN CHASE & CO | 99.105 | -35.519 | -26.4 % | 24.472.989 |
| Corient Private Wealth LLC | 3.523 | -34.823 | -90.8 % | 818.450 |
Zusätzlich aktuell von 185 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 04.05.2026 | Krish S. Krishnan (+1) | Passiv (13G/A) | 11,50 % | 3.388.283 | -0,60 pp | |
| 29.04.2026 | Vanguard Portfolio Management | Passiv (13G) | 5,05 % | 1.479.111 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,05 pp | |
| 05.02.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,40 % | 1.278.975 | -0,70 pp | |
| 14.11.2024 | Redmile Group, LLC (+1) | Passiv (13G/A) | 2,80 % | 810.245 | -3,30 pp | |
| 16.10.2024 | STATE STREET CORPORATION | Passiv (13G) | 5,10 % | 1.452.811 | Neu | |
| 10.07.2024 | The Vanguard Group | Passiv (13G/A) | 10,05 % | 2.869.136 | +1,41 pp | |
| 08.07.2024 | . BlackRock, Inc. | Passiv (13G/A) | 13,80 % | 3.947.588 | +7,40 pp | |
| 14.02.2024 | Redmile Group, LLC (+1) | Passiv (13G/A) | 6,10 % | 1.733.189 | -1,30 pp | |
| 14.02.2024 | Avoro Capital Advisors LLC (+1) | Passiv (13G/A) | 9,10 % | 2.565.555 | +3,60 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G) | 8,64 % | 2.435.774 | Neu | |
| 29.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 6,40 % | 1.809.377 | -0,20 pp | |
| 14.02.2023 | Redmile Group, LLC (+1) | Passiv (13G/A) | 7,40 % | 1.896.645 | +0,10 pp | |
| 14.02.2023 | Avoro Capital Advisors LLC (+1) | Passiv (13G) | 5,50 % | 1.410.000 | Neu | |
| 14.02.2023 | Cubist Systematic Strategies, LLC | Passiv (13G/A) | Ausstieg | 0 | -0,10 pp | |
| 14.02.2023 | Point72 Asset Management, L.P. (+2) | Passiv (13G/A) | 2,20 % | 556.252 | -5,30 pp | |
| 01.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 6,60 % | 1.698.425 | +0,20 pp | |
| 14.02.2022 | Redmile Group, LLC (+1) | Passiv (13G/A) | 7,30 % | 1.820.898 | -1,20 pp | |
| 14.02.2022 | Cubist Systematic Strategies, LLC | Passiv (13G/A) | 0,10 % | 4.514 | 0,00 pp | |
| 14.02.2022 | Point72 Asset Management, L.P. (+1) | Passiv (13G/A) | 7,50 % | 1.856.156 | +2,10 pp | |
| 14.02.2022 | Steven A. Cohen | Passiv (13G/A) | 7,50 % | 1.860.670 | +2,10 pp | |
| 03.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 6,40 % | 1.605.496 | -0,70 pp | |
| 06.12.2021 | Cubist Systematic Strategies, LLC | Passiv (13G) | 0,10 % | 1.042 | Neu | |
| 06.12.2021 | Steven A. Cohen | Passiv (13G) | 5,40 % | 1.343.242 | Neu | |
| 06.12.2021 | Point72 Asset Management, L.P. (+1) | Passiv (13G) | 5,40 % | 1.342.200 | Neu |
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 116.357.000 $ | 55.932.000 $ | 1,83 $ | 1.396.967.000 $ | 1.276.729.000 $ |
| 2025-12-31 | 10-K | 389.130.000 $ | 204.831.000 $ | 6,84 $ | 1.333.794.000 $ | 1.219.560.000 $ |
| 2025-09-30 | 10-Q | 97.800.000 $ | 79.365.000 $ | 2,66 $ | 1.240.094.000 $ | 1.137.876.000 $ |
| 2025-06-30 | 10-Q | 96.042.000 $ | 38.333.000 $ | 1,29 $ | 1.138.394.000 $ | 1.040.647.000 $ |
| 2025-03-31 | 10-Q | 88.183.000 $ | 35.733.000 $ | 1,20 $ | 1.074.416.000 $ | 984.674.000 $ |
| 2024-12-31 | 10-K | 290.515.000 $ | 89.159.000 $ | 3,00 $ | 1.055.838.000 $ | 946.380.000 $ |
| 2024-09-30 | 10-Q | 83.841.000 $ | 27.180.000 $ | 0,91 $ | 982.318.000 $ | 885.846.000 $ |
| 2024-06-30 | 10-Q | 70.284.000 $ | 15.568.000 $ | 0,53 $ | 917.658.000 $ | 838.893.000 $ |
| 2024-03-31 | 10-Q | 45.250.000 $ | 932.000 $ | 0,03 $ | 853.296.000 $ | 799.242.000 $ |
| 2023-12-31 | 10-K | 50.699.000 $ | 10.932.000 $ | 0,39 $ | 818.355.000 $ | 778.641.000 $ |
| 2023-09-30 | 10-Q | 8.556.000 $ | 80.747.000 $ | 2,79 $ | 790.350.000 $ | 755.948.000 $ |
| 2023-06-30 | 10-Q | 0 $ | -33.210.000 $ | -1,25 $ | 684.026.000 $ | 653.114.000 $ |
| 2023-03-31 | 10-Q | 0 $ | -45.297.000 $ | -1,76 $ | 531.847.000 $ | 489.566.000 $ |
| 2022-12-31 | 10-K | 0 $ | -139.975.000 $ | -5,49 $ | 558.450.000 $ | 522.231.000 $ |
| 2022-09-30 | 10-Q | 0 $ | -29.850.000 $ | -1,17 $ | 576.379.000 $ | 540.772.000 $ |
| 2022-06-30 | 10-Q | – | -28.108.000 $ | -1,10 $ | 601.324.000 $ | 559.181.000 $ |
| 2022-03-31 | 10-Q | – | -49.965.000 $ | -1,99 $ | 616.874.000 $ | 548.554.000 $ |
| 2021-12-31 | 10-K | 0 $ | -69.570.000 $ | -3,13 $ | 626.295.000 $ | 593.576.000 $ |
| 2021-09-30 | 10-Q | – | -15.589.000 $ | -0,70 $ | 451.095.000 $ | 408.237.000 $ |
| 2021-06-30 | 10-Q | – | -16.363.000 $ | -0,74 $ | 443.556.000 $ | 418.540.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 04.05.2026 | 116,4 Mio. USD | 1,83 |
| Q3 2025 | 30.09.2025 | 03.11.2025 | 97,8 Mio. USD | 2,66 |
| Q2 2025 | 30.06.2025 | 04.08.2025 | 96,0 Mio. USD | 1,29 |
| Q1 2025 | 31.03.2025 | 06.05.2025 | 88,2 Mio. USD | 1,20 |
| Q3 2024 | 30.09.2024 | 04.11.2024 | 83,8 Mio. USD | 0,91 |
| Q2 2024 | 30.06.2024 | 05.08.2024 | 70,3 Mio. USD | 0,53 |
| Q1 2024 | 31.03.2024 | 06.05.2024 | 45,3 Mio. USD | 0,03 |
| Q3 2023 | 30.09.2023 | 06.11.2023 | 8,6 Mio. USD | 2,79 |
| Q2 2023 | 30.06.2023 | 07.08.2023 | 0 USD | -1,25 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 04.05.2026 | 10-Q | 31.03.2026 | 34 Tage | SEC » |
| 17.02.2026 | 10-K | 31.12.2025 | 48 Tage | SEC » |
| 03.11.2025 | 10-Q | 30.09.2025 | 34 Tage | SEC » |
| 04.08.2025 | 10-Q | 30.06.2025 | 35 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 19.02.2025 | 10-K | 31.12.2024 | 50 Tage | SEC » |
| 04.11.2024 | 10-Q | 30.09.2024 | 35 Tage | SEC » |
| 05.08.2024 | 10-Q | 30.06.2024 | 36 Tage | SEC » |
| 06.05.2024 | 10-Q | 31.03.2024 | 36 Tage | SEC » |
| 26.02.2024 | 10-K | 31.12.2023 | 57 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 07.08.2023 | 10-Q | 30.06.2023 | 38 Tage | SEC » |
| 08.05.2023 | 10-Q | 31.03.2023 | 38 Tage | SEC » |
| 27.02.2023 | 10-K | 31.12.2022 | 58 Tage | SEC » |
| 07.11.2022 | 10-Q | 30.09.2022 | 38 Tage | SEC » |
| 08.08.2022 | 10-Q | 30.06.2022 | 39 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 08.11.2021 | 10-Q | 30.09.2021 | 39 Tage | SEC » |
| 09.08.2021 | 10-Q | 30.06.2021 | 40 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 01.03.2021 | 10-K | 31.12.2020 | 60 Tage | SEC » |
| 09.11.2020 | 10-Q | 30.09.2020 | 40 Tage | SEC » |
| 07.08.2020 | 10-Q | 30.06.2020 | 38 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 08.05.2023 | Kapitalerhöhung | $150,0 Mio | SEC » |
| 29.11.2021 | Kapitalerhöhung | $200,0 Mio | SEC » |
| 02.02.2021 | Kapitalerhöhung | $100,0 Mio | SEC » |
| 31.12.2020 | Kapitalerhöhung | $150,0 Mio | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 03.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 03.04.2026 | HV-Einladung | 15.05.2026 Jahres-HV | 23.03.2026 | DEF 14A | SEC » |
| 03.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 03.04.2025 | HV-Einladung | 16.05.2025 Jahres-HV | 25.03.2025 | DEF 14A | SEC » |
| 04.04.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 04.04.2024 | HV-Einladung | 17.05.2024 Jahres-HV | 25.03.2024 | DEF 14A | SEC » |
| 04.04.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 04.04.2023 | HV-Einladung | 19.05.2023 Jahres-HV | 22.03.2023 | DEF 14A | SEC » |
| 07.04.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 07.04.2022 | HV-Einladung | 20.05.2022 Jahres-HV | 31.03.2022 | DEF 14A | SEC » |
| 06.04.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 06.04.2021 | HV-Einladung | 21.05.2021 Jahres-HV | 25.03.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 23.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 07.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | f the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of… |
| 28.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 25.02.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 20.05.2026 | HV-Abstimmung | 0,00 | 25 | Krystal Biotech hielt am 15. Mai 2026 seine Hauptversammlung ab und wählte Krish S. Krishnan und Christopher Mason als Class III Direktoren.… 🔒 | SEC |
| 04.05.2026 | Quartalszahlen | 0,00 | 55 | Krystal Biotech kündigte am 4. Mai 2026 seine Finanzergebnisse für das erste Quartal 2026 an. Eine Pressemitteilung mit den Details wurde al… 🔒 | SEC |
| 17.02.2026 | Quartalszahlen | 0,00 | 55 | Krystal Biotech gab Finanzierungsergebnisse für das vierte Quartal und Geschäftsjahr 2025 am 17. Februar 2026 bekannt. Die Ergebnisse wurden… 🔒 | SEC |
| 12.01.2026 | Quartalszahlen | 0,00 | 25 | Krystal Biotech veröffentlicht Press Release mit vorläufigen Finanzergebnissen im Vorfeld der Präsentation auf der 44. J.P. Morgan Healthcar… 🔒 | SEC |
| 08.01.2026 | Sonstiges | 0,70 | 70 | Krystal Biotech meldet positive Zwischenergebnisse aus der Phase-1-Studie CORAL-1 für KB407 mit Bestätigung der erfolgreichen Wildtyp-CFTR-L… 🔒 | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 12.862 | 378,15 | 4.863.765 |
| 2026-06-29 | 97 | 372,25 | 36.108 |
| 2026-06-26 | 431 | 359,93 | 155.130 |
| 2026-06-18 | 3.325 | 341,66 | 1.136.020 |
| 2026-06-15 | 967 | 317,97 | 307.477 |
| 2026-06-12 | 4 | 321,55 | 1.286 |
| 2026-06-11 | 336 | 312,41 | 104.970 |
| 2026-06-09 | 11 | 301,76 | 3.319 |
| 2026-06-05 | 3 | 307,79 | 923 |
| 2026-06-04 | 387 | 301,82 | 116.804 |
| 2026-06-03 | 2.107 | 293,21 | 617.793 |
| 2026-05-29 | 1.759 | 310,30 | 545.818 |
| 2026-05-26 | 211 | 299,45 | 63.184 |
| 2026-05-20 | 2.503 | 293,30 | 734.130 |
| 2026-05-19 | 135 | 291,75 | 39.386 |
| 2026-04-21 | 6.493 | 276,50 | 1.795.315 |
| 2026-04-14 | 26 | 267,41 | 6.953 |
| 2026-03-10 | 11 | 258,65 | 2.845 |
| 2026-03-09 | 2.097 | 253,69 | 531.988 |
| 2026-02-27 | 611 | 276,36 | 168.856 |
| 2026-02-23 | 41 | 261,80 | 10.734 |
| 2026-02-19 | 24.545 | 283,29 | 6.953.353 |
| 2026-02-17 | 273 | 276,45 | 75.471 |
| 2026-02-12 | 6 | 272,65 | 1.636 |
| 2026-02-10 | 725 | 272,61 | 197.642 |
| 2026-02-09 | 2.032 | 272,74 | 554.208 |
| 2026-01-30 | 1.844 | 279,34 | 515.103 |
| 2026-01-26 | 8.529 | 281,53 | 2.401.169 |